Drugs Made in America ACQ CRP Ii; TNT ACQ Dt: 9/25/2027; Cash: $10.00

CUSIP: G2851K104 | 76 institutional holders

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile

Beneficial Ownership — 13D / 13G

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

Holder	Shares	% of Class	Change	Event Date	vs 13F
13DDrugs Made In America Acquisition II LLC	6,708,333	10.2%	New 5%+ stake	Oct 1, 2025	No 13F filer matched

13DDrugs Made In America Acquisition II LLC6,708,333

Institutional Holders — Q3 2026

Sort by

Wolverine Asset Management LLC1,842,235

0.1% of portfolio$18.8M

Context Capital Management, LLC749,605

0.2% of portfolio$7.6M

Wealthspring Capital LLC399,150

0.9% of portfolio$4.1M

Deltec Asset Management LLC50,000

0.1% of portfolio$509.0K

ABC Arbitrage SA35,000

0.0% of portfolio$356.3K

Tuttle Capital Management, LLC10,769

0.0% of portfolio$109.7K

				Style	Turnover	Location	Filed
Wolverine Asset Management LLC	1,842,235	$18.8M	0.1%	Deep Value	Very High	Chicago, IL	2026-11-02
Context Capital Management, LLC	749,605	$7.6M	0.2%	GARP	High	Greenwich, CT	2026-11-04
Wealthspring Capital LLC	399,150	$4.1M	0.9%	GARP	High	West Harrison, NY	2026-11-04
Deltec Asset Management LLC	50,000	$509.0K	0.1%	Core	Medium	New York, NY	2026-10-26
ABC Arbitrage SA	35,000	$356.3K	0.0%	Yield	Very High	Paris, India	2026-10-23
Tuttle Capital Management, LLC	10,769	$109.7K	0.0%	Growth	High	Riverside, CT	2026-10-21